EFSA sets Cannabidiol (CBD) Safety Limit

Scientists of the European Food Safety Authority (EFSA) have established a provisional safe intake level for adults for cannabidiol (CBD) as novel food. The European Commission considers that CBD qualifies as a novel food provided it meets the conditions of the EU legislation on novel foods.

Provisional Safe Level 

In an updated statement, EFSA’s expert Panel set a provisional safe intake level for CBD of approximately 2 mg/day for a 70 kg adult. The level includes an added safety factor - or uncertainty factor - to protect health despite uncertainties in the available data. The provisional safe level applies solely to food supplement formulations containing CBD with a purity of at least 98%, without nanoparticles, and for which the production process is deemed safe and genotoxicity has been excluded.

For individuals under 25 years old, pregnant and lactating women, and those on medication, EFSA’s scientists concluded that the safety of CBD cannot be established. However, the EFSA will proceed with the risk assessment of each CBD novel food application based on the data made available by the applicant.

More information is available on the EFSA website.